Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean
- 1 August 2009
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 51 (5), 615-623
- https://doi.org/10.1097/qai.0b013e3181a44f0a
Abstract
Background: Although nearly 2 million people live with HIV in Latin America and the Caribbean, mortality rates after initiation of highly active antiretroviral therapy (HAART) have not been well described. Methods: Five thousand one hundred fifty-two HIV-infected, antiretroviral-naive adults from clinics in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru starting HAART during 1996-2007 were included. First-year mortality rates and their association with demographics, regimen, baseline CD4, and clinical stage were assessed. Results: Overall 1-year mortality rate was 8.3% [95% confidence interval (CI): 7.6% to 9.1%], although variable across sites: 2.6%, 3.7%, 6.0%, 13.0%, 10.8%, 3.5%, and 9.8% for clinics in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru, respectively. Eighty percent of deaths occurred within the first 6 months. Median baseline CD4 was 107 cells per milliliter, ranging from 79 (Peru) to 163 (Argentina). Mortality estimates adjusting for CD4 were similar across sites (1.1%-2.8% for CD4 = 200), except for Haiti, 7.5%, and Honduras, 7.0%. Death was associated with lower CD4 [adjusted hazard ratio for CD4 = 200 vs. CD4 = 50 was 0.58; 95% CI: 0.40 to 0.85] and clinical AIDS (hazard ratio = 3.1; 95% CI: 2.1 to 4.5). Conclusions: Mortality rates were similar to those reported elsewhere for resource-limited settings. Disease stage at HAART initiation, treatment eligibility criteria, program age, and background mortality rates may explain some variability in prognosis between sites.Keywords
This publication has 34 references indexed in Scilit:
- Eearly loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countriesBulletin of the World Health Organization, 2008
- Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in TanzaniaBMC Infectious Diseases, 2008
- Correlates of late HIV diagnosis: implications for testing policyInternational Journal of STD & AIDS, 2007
- Scaling Up HIV Treatment in PeruJournal of the International Association of Physicians in AIDS Care, 2006
- Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and FacilitatorsPLoS Medicine, 2006
- Rapid Scale-up of Antiretroviral Therapy at Primary Care Sites in ZambiaJAMA, 2006
- The impact of malnutrition on survival and the CD4 count response in HIV‐infected patients starting antiretroviral therapyHIV Medicine, 2006
- El estigma asociado al VIH/SIDA: el caso de los prestadores de servicios de salud en MéxicoSalud Publica de Mexico, 2006
- The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infectionHIV Medicine, 2004
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986